The Federal Register

Submission for OMB Review; Comment Request

Thu, Jun 19 2008 11:00:00 GMT

Proposed Projects:

Title: DHHS/ACF/OPRE Head Start Classroombased Approaches and Resources for Emotion and Social skill promotion (CARES) project: Site Recruitment Materials.

OMB No.: New collection.

Description: The Head Start Classroombased Approaches and Resources for Emotion and Social skill promotion (CARES) project will evaluate program enhancements within Head Start settings serving three and fouryearold children. This project focuses on identifying the central features of effective programs to provide the information federal policy makers and Head Start providers will need if they are to increase Head Start's capacity to improve the social and emotional skills and school readiness of preschool age children. The project is sponsored by the Office of Planning, Research, and Evaluation (OPRE) of the Administration for Children and Families (ACF).

The Head Start CARES project will use a groupbased randomized design to test the effects of several different evidencebased st

Submission for OMB Review; Comment Request

Thu, Jun 19 2008 11:00:00 GMT

Proposed Projects:

Title: Evaluation of the Community Healthy Marriage Initiative Implementation Study.

OMB No.: 09700283.

Description: The Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS), is conducting a demonstration and evaluation called the Community Healthy Marriage Initiative
[[Page 34940]]
(CHMI). Demonstration programs have been funded through Child Support Enforcement waivers authorized under section 1115 of the Social Security Act to support healthy marriage, improve child wellbeing and increase the financial security of children. The objective of the evaluation is to: (1) Assess the implementation of community interventions designed to provide marriage education by examining the way the projects operate and by examining child support outcomes among lowincome families in the community; and (2) evaluate the community impacts of these interventions on marital stability and satisfaction, child wellbeing and child support o

1005, and 1010

Thu, Jun 19 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is amending certain medical device regulations to correct typographical errors and to ensure accuracy and clarity in the agency's regulations.

Status of Certain Additional Over-the-Counter Drug Category II Active Ingredients

Thu, Jun 19 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is proposing that certain ingredients in overthecounter (OTC) drug products are not generally recognized as safe and effective (GRASE) or are misbranded. FDA is issuing this proposed rule because we did not receive any data and information on these ingredients in response to our request on December 31, 2003 (68 FR 75585). This proposed rule is part of FDA's ongoing review of OTC drug products.

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request;

Thu, Jun 19 2008 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Office of Public Health and Science; Title XVII of the Public Health Service Act; Delegation of Authority

Thu, Jun 19 2008 11:00:00 GMT

Notice is hereby given that in furtherance of the delegation of authority to the Assistant Secretary for Health on September 28, 1979, by the Secretary of Health, Education and Welfare, the Acting Assistant Secretary for Health has delegated to the Deputy Assistant Secretary for Population Affairs all of the authorities under Title XVII of the Public Health Service Act, as amended, pertaining to the mission of the Office of Population Affairs, OSOPHS. The delegation excludes the authorities to issue regulations and to submit reports to the President. The delegation includes, but is not limited to, the authorities under sections 1704(1) and (2).

In addition, I have affirmed and ratified any actions taken by the Deputy Assistant Secretary for Population Affairs which in effect involve the exercise of the authorities delegated herein prior to the effective date of the delegation.
Redelegation

This authority may not be redelegated.

Prior Delegations

All previous delegations and redele

Center for Scientific Review; Amended Notice of Meeting

Thu, Jun 19 2008 11:00:00 GMT

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, July 15, 2008, 1 p.m. to July 15, 2008, 4 p.m., One Washington Circle Hotel, One Washington Circle, Washington, DC, 20037 which was published in the Federal Register on June 9, 2008, 73 FR 3258932590.

The meeting will be held July 8, 2008, 8 a.m. to 5 p.m. The meeting location remains the same. The meeting is closed to the public.

Dated: June 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Commiftee Policy.
[FR Doc. E813798 Filed 61808; 8:45 am]
BILLING CODE 414001M

Center for Scientific Review; Notice of Closed Meeting

Thu, Jun 19 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Neurogenetics 2.

Date: June 23, 2008.

Time: 1 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).

Contact Person: Robert C. Elliott, PhD, Scientific Review Administrato

Center for Scientific Review; Notice of Closed Meetings

Thu, Jun 19 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel, Pregnancy and Developmental Biology.

Date: July 8, 2008.

Time: 10 a.m. to 12 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call)

Contact Person: Nancy Sheard, SCD, Scientific Re

Center for Scientific Review; Cancellation of Meeting

Thu, Jun 19 2008 11:00:00 GMT

Notice is hereby given of the cancellation of the Center for Scientific Review Special Emphasis Panel, July 8, 2008, 8 a.m. to July 8, 2008, 4:30 p.m., One Washington Circle Hotel, One Washington Circle, NW., Washington, DC, 20037 which was published in the Federal Register on June 2, 2008, 73 FR 3149331495.

The meeting is cancelled due to the applications being withdrawn.

Dated: June 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E813800 Filed 61808; 8:45 am]
BILLING CODE 414001M

Center for Scientific Review; Notice of Closed Meeting

Thu, Jun 19 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: Center for Scientific Review Special Emphasis Panel, The Biochemistry and Molecular Biology of Pathogens.

Date: June 20, 2008.

Time: 11 a.m. to 2 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call)

Contact Person: Rolf Menzel, PhD,

Center for Scientific Review; Amended Notice of Meeting

Thu, Jun 19 2008 11:00:00 GMT

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, July 21, 2008, 12 p.m. to July 21, 2008, 1:30 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on June 9, 2008, 73 FR 3258932590.

The meeting will be held July 29, 2008, 2 p.m. to 3:30 p.m. The meeting location remains the same. The meeting is closed to the public.

Dated: June 10, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E813510 Filed 61808; 8:45 am]
BILLING CODE 414001M

National Institute on Deafness and Other Communication Disorders

Thu, Jun 19 2008 11:00:00 GMT

Cancellation of Meeting

Notice is hereby given of the cancellation of the Communication Disorders Review Committee, June 19, 2008, 10 a.m. to June 19, 2008, 11 a.m., The Westin Washington, DC, 1400 M Street, NW., Washington, DC 20005 which was published in the Federal Register on May 30, 2008, Vol. 73, No. 105.

This meeting is combined with the meeting being held on June 18, 2008.

Dated: June 12, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E813824 Filed 61808; 8:45 am]
BILLING CODE 414001P

National Cancer Institute; Notice of Closed Meetings

Thu, Jun 19 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c) (4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel, Adult Brain Tumor Clinical Consortium (ABTC).

Date: June 2526, 2008.

Time: 6 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.

Contact Person: Gerald G. Lovinger, PhD, Scientific Review Officer, Special Rev

National Institute of Dental & Craniofacial Research; Notice of Closed Meeting

Thu, Jun 19 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review R03s.
[[Page 34945]]

Date: July 17, 2008.

Time: 11 a.m. to 12 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call).

Conta

National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

Thu, Jun 19 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel NINDS Human Genetics Resource Center.

Date: June 18, 2008.

Time: 8 a.m. to 12 p.m.

Agenda: To review and evaluate contract proposals.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Cal

National Institute on Aging; Notice of Closed Meeting

Thu, Jun 19 2008 11:00:00 GMT

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Name of Committee: National Institute on Aging Special Emphasis Panel, Alzheimer's Disease Drug Development.

Date: June 24, 2008.

Time: 1 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institute on Aging, Gateway Bldg., 7201 Wisconsin Ave., 2C212, Bethesda, MD 20814. (Telephone Conference Call)

Contact Person: Elaine Lewis, P